Clinical evaluation of a growth factor bioavailability enhanced allograft in anterior lumbar interbody fusion (ALIF)

This study evaluated a novel GFBA and reported similar fusion rates to published reports of iliac crest bone graft (ICBG). Significant clinical improvements and no GFBA related complications or revision/reoperations were reported. This is the first study evaluating GFBA and demonstrated its safety and efficacy in ALIF procedures for DDD.